Dynavax Technologies
DVAX
#5048
Rank
A$2.64 B
Marketcap
A$22.49
Share price
0.00%
Change (1 day)
4.30%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -A$58.75 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$54.62 Million, an increase over its 2023 earnings that were of A$3.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.75 Million-207.55%
2024 A$54.62 M1475.31%
2023 A$3.46 M-99.2%
2022 A$0.43 B238.78%
2021 A$0.12 B-257.89%
2020 -A$81.51 Million-58.58%
2019 -A$0.2 Billion-9.32%
2018 -A$0.22 Billion60.44%
2017 -A$0.14 Billion-15.8%
2016 -A$0.17 Billion4.22%
2015 -A$0.16 Billion16.54%
2014 -A$0.14 Billion37.09%
2013 -A$96.47 Million
2010 -A$69.05 Million214.85%
2009 -A$21.93 Million-37.33%
2008 -A$35 Million-66.07%
2007 -A$0.11 Billion16.92%
2006 -A$88.22 Million170.36%
2005 -A$32.63 Million33.39%
2004 -A$24.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.02 B-20,481.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.92 B-30,455.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$1.46 B-3,084.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$2.84 Billion 5,669.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.15 B-22,792.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.79 B-42,392.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$10.37 B-21,212.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
A$0.21 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.32 B-4,836.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel